Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL

Blood

Volumn 101, Issue 7, 2003, Pages 2743-2747

  Stams, Wendy A G ^a   Den Boer, Monique L ^b   Beverloo, H Berna ^b   Meijerink, Jules P P ^b   Stigter, Rolinda L ^b   Van Wering, Elisabeth R ^b   Janka Schaub, Gritta E ^b   Slater, Rosalyn ^b   Pieters, Rob ^b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; ASPARTATE AMMONIA LIGASE; MESSENGER RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD CULTURE; BONE MARROW CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ACUTE LYMPHOCYTIC LEUKEMIA; BIOSYNTHESIS; CASE CONTROL STUDY; CHILD; CHROMOSOME 12; CHROMOSOME 21; CHRONIC LYMPHATIC LEUKEMIA; DRUG EFFECT; ENZYMOLOGY; GENE TRANSLOCATION; GENETICS; INFANT; PRESCHOOL CHILD;

ASPARAGINASE; ASPARTATE-AMMONIA LIGASE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 21; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, LYMPHOCYTIC, CHRONIC; RNA, MESSENGER; TRANSLOCATION, GENETIC; UP-REGULATION;

EID: 0038784374     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-08-2446     Document Type: Article

References (36)

1. Poirel H, Oury C, Carron C, et al. The TEL gene products: nuclear phosphoproteins with DNA binding properties. Oncogene. 1997;14:349-357.
2. Meyers S, Downing JR, Hiebert SW. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol. 1993;13:6336-6345.
3. McLean TW, Ringold S, Neuberg D, et al. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood. 1996;88:4252-4258.
4. Borkhardt A, Cazzaniga G, Viehmann S, et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Bedin-Frankfurt-Munster Study Group. Blood. 1997;90:571-577.
5. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood. 1997;90:4933-4937.
6. Loh ML, Silverman LB, Young ML, et al. Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. Blood. 1998;92:4792-4797.
7. Seeger K, Adams HP, Buchwald D, et al. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia: the Berlin-Frankfurt-Munster Study Group. Blood. 1998;91:1716-1722.
8. Rubnitz JE, Behm FG, Wichlan D, et al. Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup. Leukemia. 1999;13:19-21.
9. Jamil A, Theil KS, Kahwash S, Ruymann FB, Klopfenstein KJ. TEL-AML-1 fusion gene: its frequency and prognostic significance in childhood acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2000;122:73-78.
10. Ramakers-van Woerden NL, Pieters R, Loonen AH, et al. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood. 2000;96:1094-1099.
11. Kaspers GJL, Veerman AJP, Pieters R, et al. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood. 1997;90:2723-2729.
12. Asselin BL, Kreissman S, Coppola DJ, et al. Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1999;21:6-12.
13. Chakrabarti R, Schuster SM. I-asparaginase: perspectives on the mechanisms of action and resistance. Int J Pediatric Hematol Oncol. 1997;4:597-611.
14. Ohnuma T, Holland JF, Freeman A. Biochemical and pharmacological studies with asparaginase in man. Cancer Res. 1970;30:2297-2305.
15. Miller HK, Salser JS, Balis ME. Amino acid levels following L-asparaginase amidohydrolase (EC.3.5.1.1.) therapy. Cancer Res. 1969;29:183-187.
16. Aslanian AM, Fletcher BS, Kilberg MS. Asparagine synthetase expression alone is sufficient to induce L-asparaginase resistance in MOLT-4 human leukemia cells. Biochem J. 2001;357:321-328.
17. Hiebert SW, Sun WH, Davis JN, et al. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol. 1996;16:1349-1355.
18. Kaspers GJ, Veerman AJ, Pieters R, et al. Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. Br J Cancer. 1994;70:1047-1052.
19. Hagemeijer A, Buijs A, Smit E, et al. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosomes Cancer. 1993;8:237-245.
20. Pieters R, Loonen AH, Huismans DR, et al. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood. 1990;76:2327-2336.
21. Pieters R, Huismans DR, Leyva A, Veerman AJ. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. Cancer Lett. 1988;41:323-332.
22. Meijerink J, Mandigers C, van de Locht L, Tonissen E, Goodsaid F, Raemakers J. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR. J Mol Diagn. 2001;3:55-61.
23. Pieters R, Huismans DR, Loonen AH, et al. Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet. 1991;338:399-403.
24. Prager MD, Bachynsky N. Asparagine synthetase in asparaginase resistant and susceptible mouse lymphomas. Biochem Biophys Res Commun. 1968;31:43-47.
25. Kiriyama Y, Kubota M, Takimoto T, et al. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase. Leukemia. 1989;3:294-297.
26. Worton KS, Kerbel RS, Andrulis IL. Hypomethylation and reactivation of the asparagine synthetase gene induced by L-asparaginase and ethyl methanesulfonate. Cancer Res. 1991;51:985-989.
27. Martin JK, Sun W, Maraga D, Schuster SM, Wylie DE. An investigation into the mechanism of L-asparaginase resistance in L5178Y murine leukemia cells. Amino Acids. 1993;5:51-69.
28. Hutson RG, Kitoh T, Amador DAM, Cosic S, Schuster SM, Kilberg MS. Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells. Am J Physiol. 1997;272:C1691-C1699.
29. Haskell CM, Canellos GP. L-asparaginase resistance in human leukemia-asparagine synthetase. Biochem Pharmacol. 1969;18:2578-2580.
30. Dübbers A, Würthwein G, Müller HJ, et al. Asparagine synthetase activity in paediatric acute leukemias: AML-M5 subtype shows lowest activity. Br J Hematol. 2000;109:427-429.
31. Tsang KS, Li CK, Chik KW, et al. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong. Am J Hematol. 2001;68:91-98.
32. Hubeek I, Ramakers-van Woerden NL, Pieters R, et al. TEL-AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukemia. Br J Haematol. 2001;113:254-255.
33. Takahashi Y, Horibe K, Kiyoi H, et al. Prognostic significance of TEL/AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1998;20:190-195.
34. Aslanian AM, Kilberg MS. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells. Biochem J. 2001;358:59-67.
35. Fumarola C, Zerbini A, Guidotti GG. Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis. Cell Death Differ. 2001;8:1004-1013.
36. Krishna Narla R, Navara C, Sarquis M, Uckun FM. Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells. Leuk Lymphoma. 2001;41:615-623.